Navigation Links
Solos Endoscopy, Inc. Receives Purchase Order from the National Cancer Institute

BOSTON, Sept. 17 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received multiple purchase orders for its MammoView(TM) line of surgical endoscopy instruments from the National Cancer Institute (NCI), Bethesda MD. NCI is 1 of 27 Institutes and Centers that comprise the U.S. National Institutes of Health (NIH), which is part of the U.S. Department of Health and Human Services.

NCI has built a national network that includes regional and community cancer centers, physicians who are cancer specialists, cooperative groups of clinical researchers, and volunteer and community outreach groups throughout the U.S. and works closely with similar institutions worldwide.

Solos Endoscopy's MammoView(TM) system employs advanced micro endoscopes and optical technology to give physicians sharp, clear images of the milk ducts where the majority of breast cancers arise.

"We are very pleased to be supplying our MammoView(TM) system top cancer care and research organization in the world. We believe that our system will get well deserved exposure through the infrastructure NCI provides for basic, translational and clinical research activities encompassing all aspects of cancer, including biology, genetics, epidemiology, detection, diagnosis, treatment, prevention, palliative care and survivorship," stated Bob Segersten, President of Solos Endoscopy, Inc.

For more information on the National Cancer Institute, please visit:

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

SOURCE Solos Endoscopy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Solos Endoscopy, Inc. Receives Purchase Order from One of the Major Healthcare Systems in Missouri
2. Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
3. Solos Endoscopy, Inc. Develops Specialized Endocoupler for the MammoView(TM)
4. Solos Endoscopy, Inc. Receives Purchase Order from Leading San Diego Healthcare Provider
5. Solos Endoscopy, Inc. Successfully Completes FDA Inspection
6. Solos Endoscopy, Inc. Receives Purchase Order from Major Connecticut Hospital for the MammoView(TM)
7. Solos Endoscopy, Inc.s Breast Endoscopy System Featured in January Issue of Outpatient Surgery Magazine
8. Solos Endoscopy, Inc.s MammoView(TM) Featured in December Issue of Surgical Products Magazine
9. Solos Endoscopy, Inc. Posts First Nine Months Financials for 2008 on
10. Solos Endoscopy, Inc. Receives Purchase Order from Cleveland Clinic
11. Solos Endoscopy, Inc. Increases Sales Revenue for October 2008 by Over 10% as Compared to Last Year
Post Your Comments:
(Date:11/27/2015)... Canada (PRWEB) , ... November 28, 2015 , ... There ... do we outperform our billings from last year? , This question has not been ... organizations are coming to the retirement age and the younger workforce don’t share the ...
(Date:11/27/2015)... NC (PRWEB) , ... November 27, 2015 , ... A ... effective ways to treat it. Surviving Mesothelioma has just posted the findings on ... at University Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ProSidebar: ... in Final Cut Pro X. With ProSidebar: Fasion, video editors can easily add ... ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop zones, lines, ...
(Date:11/27/2015)... ... November 27, 2015 , ... The moment you ... for not only fulfilling the needs of advisers and clients but going above ... and providing top-tier customer service. However, there's always room for improvement, which is ...
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, ... posters. This is one of Joplin's most famous and beautiful concert posters. The concert ... Michigan in Ann Arbor. The According to Hawley, "It is hard to believe that ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... STOCKHOLM , November 26, 2015 ... the potential to use SyMRI to find optimal contrast weighting ... brain tumor metastases, and has signed a research agreement with ... at the hospital. Using SyMRI, it is possible to generate ... parameter settings after the patient has left, thus making it ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Cell Surface Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
(Date:11/26/2015)... 26, 2015 ... adds "Global Repaglinide Industry 2015 ... on China Repaglinide Market, 2010-2019" reports ... and information to its online business ... . --> ...
Breaking Medicine Technology: